Karyopharm Therapeutics Inc. (KPTI) total debt

Total debt · fiscal 2025
$233.61M

Karyopharm Therapeutics Inc. (KPTI) carried total debt of $233.61M at the end of fiscal 2025 (December 31, 2025). That is 20.1% higher than the $194.52M of fiscal 2024. Figures as of 18 Nov 2026, 08:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$233.61M
Change on fiscal 2024
+20.1%
Highest on record
$233.61Mfiscal 2025
Lowest on record
$169.29Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Karyopharm Therapeutics Inc. total debt, in more detail

Across the 5 fiscal years on record (2021–2025), the highest was $233.61M in fiscal 2025 and the lowest $169.29M in fiscal 2021.

History · 5 fiscal years

Total debt by fiscal year

Karyopharm Therapeutics Inc. total debt, year by year

Karyopharm Therapeutics Inc. (KPTI) total debt by fiscal year
Fiscal yearTotal debtChangeYear ended
2025$233.61M 20.1% up
2024$194.52M 9.9% up
2023$177.02M 1.1% down
2022$179.07M 5.8% up
2021$169.29M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on KPTI

Karyopharm Therapeutics Inc., figure by figure

Karyopharm Therapeutics Inc. (KPTI) overview: price, valuation and scorecard

Karyopharm Therapeutics Inc. total debt: questions and answers

How much debt does Karyopharm Therapeutics Inc. have?

Karyopharm Therapeutics Inc. (KPTI) carried total debt of $233.61M at the end of fiscal 2025 (December 31, 2025). That is 20.1% higher than the $194.52M of fiscal 2024.

What are the highest and lowest total debt figures on record for Karyopharm Therapeutics Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was $233.61M in fiscal 2025 and the lowest $169.29M in fiscal 2021.

How is Karyopharm Therapeutics Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Karyopharm Therapeutics Inc. (KPTI) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/KPTI/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.